Item Type | Name |
Academic Article
|
Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease.
|
Academic Article
|
The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease.
|
Academic Article
|
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
|
Academic Article
|
Clinical profile of donepezil in the treatment of Alzheimer's disease.
|
Academic Article
|
Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
|
Academic Article
|
Baylor profound mental status examination: a brief staging measure for profoundly demented Alzheimer disease patients.
|
Academic Article
|
Therapeutic standards in Alzheimer disease.
|
Academic Article
|
Vitamin E and donepezil for the treatment of mild cognitive impairment.
|
Academic Article
|
Influence of premorbid IQ and education on progression of Alzheimer's disease.
|
Academic Article
|
Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type.
|
Academic Article
|
Memantine in moderate-to-severe Alzheimer's disease.
|
Academic Article
|
Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
|
Academic Article
|
Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
|
Academic Article
|
The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
|
Academic Article
|
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
|
Academic Article
|
Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
|
Academic Article
|
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.
|
Academic Article
|
Factors affecting deficit awareness in persons with dementia.
|
Academic Article
|
Factor structure of the Geriatric Depression Scale and relationships with cognition and function in Alzheimer's disease.
|
Academic Article
|
Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response.
|
Academic Article
|
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.
|
Academic Article
|
Is functional decline necessary for a diagnosis of Alzheimer's disease?
|
Academic Article
|
Alzheimer's disease and mild cognitive impairment deteriorate fine movement control.
|
Academic Article
|
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
|
Academic Article
|
Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials.
|
Academic Article
|
Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study.
|
Academic Article
|
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
|
Academic Article
|
Identifying amnestic mild cognitive impairment in primary care: a feasibility study.
|
Academic Article
|
Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls.
|
Academic Article
|
Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.
|
Academic Article
|
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
|
Academic Article
|
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.
|
Academic Article
|
Current treatments for Alzheimer's disease: cholinesterase inhibitors.
|
Academic Article
|
Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III).
|
Academic Article
|
Self-reported awareness of performance in dementia.
|
Academic Article
|
Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.
|
Academic Article
|
How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
|
Academic Article
|
Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.
|
Academic Article
|
Report of the task force on designing clinical trials in early (predementia) AD.
|
Concept
|
Cognition Disorders
|
Concept
|
Cognition
|
Academic Article
|
A phase 3 trial of semagacestat for treatment of Alzheimer's disease.
|
Academic Article
|
Molecular neuropsychology: creation of test-specific blood biomarker algorithms.
|
Academic Article
|
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
|
Academic Article
|
Validation of the Spanish version of the Baylor Profound Mental Status Examination.
|
Academic Article
|
How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
|
Academic Article
|
Prevalence and correlates of cognitive asymmetry in a large sample of Alzheimer's disease patients.
|
Academic Article
|
Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease.
|
Academic Article
|
Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
|
Academic Article
|
Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
|
Academic Article
|
Chinese Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer's Disease.
|
Academic Article
|
Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
|